---

Medical Advocates Ethics and Infectious Diseases
		Ethical Challenges Screening/Testing Refusal of Care/Services Detention Patient Exploitation Compulsory Treatment Decision-Making Reproduction Transplants End-of-Life Care Enteral Nutrition Professional Associations National Challenges         Sterilization Bioterrorism                     Prison Challenges HIV Exceptionalism           Conflicts of Interest Pharmaceutical Industry   Pregnancy HIV Prevention    Stigma Physician Reimbursement  Ethics and Disease Challenges and Duties HIV Cure Ebola Virus Disease Executions

---

Ethics Main Page

Main New and Noteworthy

Home Page

---

Medical Advocates Pegylated Interferon Alfa-2a (Pegasys)

HIV/HBV Indication New and Noteworthy Safety

---

Peg Inf alfa 2a Main

Main New/Newsworthy

Home Page

---

Last Update:  October 22, 2008  Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader New and Noteworthy July 2007   Safety and Tolerability of Sequential Pegylated IFN-alpha2a and Tenofovir for Hepatitis B Infection in HIV+ Individuals. Johnson; Ristig; Overton; et al  HIV Clin Trials. 2007 May-Jun;8(3):173-81.